OvAd1, a novel, potent, and selective chimeric oncolytic virus developed for ovarian cancer by 3D-directed evolution by Kuhn, I, Bauzon, M, Green, N, Seymour, L, Fisher, K, Hermiston, T

Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus by Illingworth, S, Di, Y, Bauzon, M, Lei, J, Duffy, M, Alvis, S, Champion, B, Lieber, A, Hermiston, T, Seymour, L, Beadle, J, Fisher, K

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer by Kuhn, I, Harden, P, Bauzon, M, Chartier, C, Nye, J, Thorne, S, Reid, T, Ni, S, Lieber, A, Fisher, K, Seymour, L, Rubanyi, G, Harkins, R, Hermiston, T